Zacks.com on MSN16h
Atara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the UpgradeAtara Biotherapeutics (ATRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback